You are here
News
Budget 2021 Bolsters Canada’s Bio-Economy and Genomics on a Mission
Monday, April 19, 2021
Funding announced in Budget 2021 will significantly advance Canadian bioscience research and innovation, accelerating ground-breaking missions in critical public health areas like pandemic surveillance and precision medicine in the clinic, while delivering made-in-Canada solutions to anti-microbial resistance, food security and biomanufacturing.
Genome Canada announces new Canadian SARS-CoV-2 Data Portal
Tuesday, March 23, 2021
A Made-in-Canada data solution to support Canada’s Variants of Concern Strategy
Genome Canada, in partnership with the Government of Canada, is pleased to announce the development of a new Canadian SARS-CoV-2 Data Portal that will manage and facilitate data sharing of viral genome sequences among Canadian public health labs, researchers and other groups interested in accessing the data for research and innovation purposes.
New applied genomics research investments bring solutions to real-world challenges facing Canadians
Tuesday, March 9, 2021
$8.6 million in federal funding to support healthier Canadians and a resilient food supply
Genomics is on a mission to develop new knowledge, tools and technologies to improve Canadians’ lives.
Integrated Variants of Concern Strategy to track fast-spreading SARS-CoV-2 variants
Friday, February 12, 2021
Reducing the impact of novel SARS-CoV-2 variants is a critical focus of the global COVID-19 response. Genome Canada, through its leadership of the Canadian COVID Genomics Network (CanCOGeN), is part of an integrated national effort to rapidly identify, understand, and track the distribution of these variants in Canada.
Genome Canada named National Capital Region Top Employer
Tuesday, February 2, 2021
As Genome Canada continues its leading role in Canada’s COVID-19 public health response, the organization has been named a 2021 Top
Updated statement on CanCOGeN and SARS-CoV-2 variants of concern
Monday, January 18, 2021
(This statement is an updated version of our original statement of Dec. 22, 2020 when the first new variant was identified in the United Kingdom.)